Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 440-443 |
| Number of pages | 4 |
| Journal | HIV Medicine |
| Volume | 18 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2017 |
Fingerprint
Keywords
- birth weight
- HIV
- HIV RNA
- pregnancy
- preterm delivery
- anti human immunodeficiency virus agent
- virus RNA
- adult
- age
- antiretroviral therapy
- Article
- body weight
- CD4 lymphocyte count
- female
- human
- Human immunodeficiency virus
- Human immunodeficiency virus infected patient
- Human immunodeficiency virus infection
- low birth weight
- major clinical study
- pregnancy outcome
- pregnancy rate
- pregnancy termination
- pregnant woman
- premature labor
- primigravida
- priority journal
- social determinants of health
- virus load
Cite this
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women. / Floridia, M.; Tamburrini, E.; Masuelli, G.; Martinelli, P.; Spinillo, A.; Liuzzi, G.; Vimercati, A.; Alberico, S.; Maccabruni, A.; Pinnetti, C.; Frisina, V.; Dalzero, S.; Ravizza, M.; Pregnancy, The Italian Group for Surveillance of Antiretroviral Treatment in; Mori, F.; Ortolani, P.; dalle Nogare, E.R.; Di Lorenzo, F.; Sterrantino, G.; Meli, M.; Polemi, S.; Nocentini, J.; Baldini, M.; Montorzi, G.; Mazzetti, M.; Rogasi, P.; Borchi, B.; Vichi, F.; Del Pin, B.; Pinter, E.; Grilli, E.; Mariani, B.; Nardini, G.; Molinari, A.; Sabbatini, F.; Grossi, P.; Maso, G.; Roccio, M.; Capone, A.; Bucceri, A.; Scaravelli, G.; Castelli Gattinara, G.; Pirillo, M.F.; Amici, R.; Galluzzo, C.M.; Baroncelli, S.; Villani, P.; Cusato, M.; Parazzini, F.; Vella, S.
In: HIV Medicine, Vol. 18, No. 6, 2017, p. 440-443.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rate, correlates and outcomes of repeat pregnancy in HIV-infected women
AU - Floridia, M.
AU - Tamburrini, E.
AU - Masuelli, G.
AU - Martinelli, P.
AU - Spinillo, A.
AU - Liuzzi, G.
AU - Vimercati, A.
AU - Alberico, S.
AU - Maccabruni, A.
AU - Pinnetti, C.
AU - Frisina, V.
AU - Dalzero, S.
AU - Ravizza, M.
AU - Pregnancy, The Italian Group for Surveillance of Antiretroviral Treatment in
AU - Mori, F.
AU - Ortolani, P.
AU - dalle Nogare, E.R.
AU - Di Lorenzo, F.
AU - Sterrantino, G.
AU - Meli, M.
AU - Polemi, S.
AU - Nocentini, J.
AU - Baldini, M.
AU - Montorzi, G.
AU - Mazzetti, M.
AU - Rogasi, P.
AU - Borchi, B.
AU - Vichi, F.
AU - Del Pin, B.
AU - Pinter, E.
AU - Grilli, E.
AU - Mariani, B.
AU - Nardini, G.
AU - Molinari, A.
AU - Sabbatini, F.
AU - Grossi, P.
AU - Maso, G.
AU - Roccio, M.
AU - Capone, A.
AU - Bucceri, A.
AU - Scaravelli, G.
AU - Castelli Gattinara, G.
AU - Pirillo, M.F.
AU - Amici, R.
AU - Galluzzo, C.M.
AU - Baroncelli, S.
AU - Villani, P.
AU - Cusato, M.
AU - Parazzini, F.
AU - Vella, S.
N1 - Cited By :1 Export Date: 19 April 2018 CODEN: HMIEA Correspondence Address: Floridia, M.; Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di SanitàItaly; email: marco.floridia@iss.it Funding details: H85E08000200005, ISS, Istituto Superiore di Sanità Funding details: AIFA, Agenzia Italiana del Farmaco, Ministero della Salute Funding details: HHMI, Howard Hughes Medical Institute Funding details: NIH, National Institutes of Health Funding details: Wellcome Trust Funding text: We thank Cosimo Polizzi and Alessandra Mattei of the Istituto Superiore di Sanit? in Rome, Italy, for providing technical secretarial support for this study. No compensation was received for this contribution. Conflicts of interest: The authors report no conflicts of interest. Funding: This work was supported by public research grants (ref.: H85E08000200005) from the Italian Medicines Agency (AIFA). No funding was received for this work from any of the following organizations: National Institutes of Health (NIH), Wellcome Trust, and the Howard Hughes Medical Institute (HHMI). The funder had no role in the study design, data collection, data analysis, manuscript preparation and/or publication decision. References: Cliffe, S., Townsend, C.L., Cortina-Borja, M., Newell, M.L., Fertility intentions of HIV-infected women in the United Kingdom (2011) AIDS Care, 23, pp. 1093-1101; Hernando, V., Alejos, B., Álvarez, D., Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study (2014) BMC Pregnancy Childbirth, 14, p. 194; French, C.E., Cortina-Borja, M., Thorne, C., Tookey, P.A., Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990–2009 (2012) J Acquir Immune Defic Syndr, 59, pp. 287-293; Floridia, M., Ravizza, M., Tamburrini, E., Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy (2006) Epidemiol Infect, 134, pp. 1120-1127; Bertino, E., Spada, E., Occhi, L., Neonatal anthropometric charts: the Italian neonatal study compared with other European studies (2010) J Pediatr Gastroenterol Nutr, 51, pp. 353-361; Bryant, A.S., Leighty, R.M., Shen, X., Predictors of repeat pregnancy among HIV-1-infected women (2007) J Acquir Immune Defic Syndr, 44, pp. 87-92; Friedman, R.K., Bastos, F.I., Leite, I.C., Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil (2011) Rev Saude Publica, 45, pp. 373-381; Akelo, V., McLellan-Lemal, E., Toledo, L., Determinants and experiences of repeat pregnancy among HIV-positive Kenyan women - a mixed-methods analysis (2015) PLoS One, 10; Kreitchmann, R., Megazzini, K., Melo, V.H., Repeat pregnancy in women with HIV infection in Latin America and the Caribbean (2015) AIDS Care, 27, pp. 1289-1297; (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach, , Geneva, Switzerland, World Health Organization; Short, C.E., Douglas, M., Smith, J.H., Taylor, G.P., Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission (2014) HIV Med, 15, pp. 233-238; French, C.E., Thorne, C., Tariq, S., Cortina-Borja, M., Tookey, P.A., Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? (2014) AIDS, 28, pp. 1369-1372
PY - 2017
Y1 - 2017
N2 - Objectives: The aim of the study was to assess the rate, determinants, and outcomes of repeat pregnancies in women with HIV infection. Methods: Data from a national study of pregnant women with HIV infection were used. Main outcomes were preterm delivery, low birth weight, CD4 cell count and HIV plasma viral load. Results: The rate of repeat pregnancy among 3007 women was 16.2%. Women with a repeat pregnancy were on average younger than those with a single pregnancy (median age 30 vs. 33 years, respectively), more recently diagnosed with HIV infection (median time since diagnosis 25 vs. 51 months, respectively), and more frequently of foreign origin [odds ratio (OR) 1.36; 95% confidence interval (CI) 1.10–1.68], diagnosed with HIV infection in the current pregnancy (OR: 1.69; 95% CI: 1.35–2.11), and at their first pregnancy (OR: 1.33; 95% CI: 1.06–1.66). In women with sequential pregnancies, compared with the first pregnancy, several outcomes showed a significant improvement in the second pregnancy, with a higher rate of antiretroviral treatment at conception (39.0 vs. 65.4%, respectively), better median maternal weight at the start of pregnancy (60 vs. 61 kg, respectively), a higher rate of end-of-pregnancy undetectable HIV RNA (60.7 vs. 71.6%, respectively), a higher median birth weight (2815 vs. 2885 g, respectively), lower rates of preterm delivery (23.0 vs. 17.7%, respectively) and of low birth weight (23.4 vs. 15.4%, respectively), and a higher median CD4 cell count (+47 cells/μL), with almost no clinical progression to Centers for Disease Control and Prevention stage C (CDC-C) HIV disease (0.3%). The second pregnancy was significantly more likely to end in voluntary termination than the first pregnancy (11.4 vs. 6.1%, respectively). Conclusions: Younger and foreign women were more likely to have a repeat pregnancy; in women with sequential pregnancies, the second pregnancy was characterized by a significant improvement in several outcomes, suggesting that women with HIV infection who desire multiple children may proceed safely and confidently with subsequent pregnancies. © 2016 British HIV Association
AB - Objectives: The aim of the study was to assess the rate, determinants, and outcomes of repeat pregnancies in women with HIV infection. Methods: Data from a national study of pregnant women with HIV infection were used. Main outcomes were preterm delivery, low birth weight, CD4 cell count and HIV plasma viral load. Results: The rate of repeat pregnancy among 3007 women was 16.2%. Women with a repeat pregnancy were on average younger than those with a single pregnancy (median age 30 vs. 33 years, respectively), more recently diagnosed with HIV infection (median time since diagnosis 25 vs. 51 months, respectively), and more frequently of foreign origin [odds ratio (OR) 1.36; 95% confidence interval (CI) 1.10–1.68], diagnosed with HIV infection in the current pregnancy (OR: 1.69; 95% CI: 1.35–2.11), and at their first pregnancy (OR: 1.33; 95% CI: 1.06–1.66). In women with sequential pregnancies, compared with the first pregnancy, several outcomes showed a significant improvement in the second pregnancy, with a higher rate of antiretroviral treatment at conception (39.0 vs. 65.4%, respectively), better median maternal weight at the start of pregnancy (60 vs. 61 kg, respectively), a higher rate of end-of-pregnancy undetectable HIV RNA (60.7 vs. 71.6%, respectively), a higher median birth weight (2815 vs. 2885 g, respectively), lower rates of preterm delivery (23.0 vs. 17.7%, respectively) and of low birth weight (23.4 vs. 15.4%, respectively), and a higher median CD4 cell count (+47 cells/μL), with almost no clinical progression to Centers for Disease Control and Prevention stage C (CDC-C) HIV disease (0.3%). The second pregnancy was significantly more likely to end in voluntary termination than the first pregnancy (11.4 vs. 6.1%, respectively). Conclusions: Younger and foreign women were more likely to have a repeat pregnancy; in women with sequential pregnancies, the second pregnancy was characterized by a significant improvement in several outcomes, suggesting that women with HIV infection who desire multiple children may proceed safely and confidently with subsequent pregnancies. © 2016 British HIV Association
KW - birth weight
KW - HIV
KW - HIV RNA
KW - pregnancy
KW - preterm delivery
KW - anti human immunodeficiency virus agent
KW - virus RNA
KW - adult
KW - age
KW - antiretroviral therapy
KW - Article
KW - body weight
KW - CD4 lymphocyte count
KW - female
KW - human
KW - Human immunodeficiency virus
KW - Human immunodeficiency virus infected patient
KW - Human immunodeficiency virus infection
KW - low birth weight
KW - major clinical study
KW - pregnancy outcome
KW - pregnancy rate
KW - pregnancy termination
KW - pregnant woman
KW - premature labor
KW - primigravida
KW - priority journal
KW - social determinants of health
KW - virus load
U2 - 10.1111/hiv.12473
DO - 10.1111/hiv.12473
M3 - Article
VL - 18
SP - 440
EP - 443
JO - HIV Medicine
JF - HIV Medicine
SN - 1464-2662
IS - 6
ER -